DICE Therapeutics, Inc.

DICE · NASDAQ
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Assets
Cash & Equivalents$73,464$101,594$461,393$48,271
Short-Term Investments$454,919$452,954$112,832$218,343
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,921$4,802$3,537$1,223
Total Curr. Assets$532,304$559,350$577,762$267,837
Property Plant & Equip (Net)$16,753$16,056$16,018$16,488
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,616$198$198$669
Total NC Assets$18,369$16,254$16,216$17,157
Other Assets$0$0$0$0
Total Assets$550,673$575,604$593,978$284,994
Liabilities
Payables$3,414$4,122$3,075$1,388
Short-Term Debt$1,534$1,479$1,424$1,372
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$15,623$11,640$10,650$8,905
Total Curr. Liab.$20,571$17,241$15,149$11,665
LT Debt$11,046$11,458$11,841$12,215
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$11,046$11,458$11,841$12,215
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$31,617$28,699$26,990$23,880
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$5$4
Retained Earnings-$248,056-$213,240-$187,594-$164,370
AOCI$2-$297-$597-$1,318
Other Equity$767,105$292$592$426,798
Total Equity$519,056-$213,240-$187,594$261,114
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$550,673-$184,541-$160,604$284,994
Net Debt-$60,884-$88,657-$448,128-$34,684